FUJI Media Holdings
4676
Remixpoint
3825
Mitsubishi Heavy Industries
7011
4
SoftBank
9434
5
Metaplanet
3350
JP Stock MarketDetailed Quotes
197A Tauns Laboratories
- 614
- 00.00%
20min DelayMarket Closed Jan 24 15:30 JST
62.50BMarket Cap11.37P/E (Static)
621High605Low848.70KVolume617Open614Pre Close519.64MTurnover73352wk High3.75%Turnover Ratio101.78MShares40152wk Low53.99EPS TTM13.88BFloat Cap733Historical High11.37P/E (Static)22.61MShs Float401Historical Low53.99EPS LYR2.61%Amplitude11.00Dividend TTM4.53P/B100Lot Size1.73%Div YieldTTM
Tauns Laboratories News
Tauns Laboratories: (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
Tauns Laboratories: (Progress of disclosure matters) Notice of conclusion of a basic transaction agreement with Roche Diagnostics Co., Ltd.
Tauns Laboratories: Correction report (Large shareholding report / Change report)
Tauns Laboratories: Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
Tauns Laboratories: Notice of conclusion of a basic agreement on the basic transaction agreement between Towns and Roche Diagnostics
Tauns Laboratories: change report
Tauns Laboratories: Change report.
Tauns Laboratories: Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
Tauns Laboratories: Notice regarding preparations for applying for a change in market classification to the Tokyo Stock Exchange Prime Market
Tauns Laboratories: Summary of financial results for the 1st quarter of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)
Tauns Laboratories: Supplementary Material on Financial Results for the Three Months Ended September 30, 2024
Tauns Laboratories: Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Presentation of financial results for the 1st quarter of the fiscal year ending 2025/6
Tauns Laboratories: Notice of participation in Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Participation in the Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Conclusion of License Agreement with First Screening Corp.
Tauns Laboratories: Notice of signing a license agreement with First Screening Co., Ltd.
Tauns Laboratories: Announcement of Acquisition of "Kurumin" Certification as a Child-Rearing Support Company
Tauns Laboratories: Notice of obtaining “Kurumin” certification as a child-rearing support company
Tauns Laboratories: Corporate Governance Report 2024/09/30